Prescription practices for chronic obstructive pulmonary disease: Findings from the national ambulatory medical care survey 1999-2010

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 3, 2014, Pages 247-255

  Ford, Earl S ^a   Mannino, David M ^b   Giles, Wayne H ^a   Wheaton, Anne G ^a   Liu, Yong ^a   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

COPD; Prescriptions; Therapeutics; Trends

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; LONG ACTING DRUG; ORCIPRENALINE; SALMETEROL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; DELAYED RELEASE FORMULATION; DRUG COMBINATION; METHYLXANTHINE; SCOPOLAMINE DERIVATIVE; XANTHINE DERIVATIVE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SYMPTOM; UNITED STATES; DELAYED RELEASE FORMULATION; DRUG COMBINATION; DRUG UTILIZATION; HEALTH CARE SURVEY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; THERAPEUTIC USE; TRENDS;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; IPRATROPIUM; MALE; MIDDLE AGED; OFFICE VISITS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; UNITED STATES; XANTHINES;

EID: 84900824765     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.840570     Document Type: Article

References (20)

1. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4(7):502-506. (Pubitemid 47547843)
2. Soriano JB, Rodriguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation Proc Am Thorac Soc 2011; 8(4):363-367.
3. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fl uticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356(8):775-789. (Pubitemid 46294610)
4. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359(15):1543-1554.
5. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fl uticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177(1):19-26.
6. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10):948-955.
7. Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Molken MP, Beeh KM, Rabe KF, Fabbri LM. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364(12):1093-1103.
8. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 Pt 2):S77-121.
9. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, Owens DK. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2007; 147(9):633-638. (Pubitemid 351664484)
10. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schunemann H, Wedzicha W, MacDonald R, Shekelle P. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155(3):179-191.
11. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of COPD. Revised 2011. 2011. Available from: http://www.goldcopd.org/.Accessed 3 February 2012.
12. Centers for Disease Control and Prevention: Ambulatory Health Care Data. 2012. Available from: http://www.cdc.gov/nchs/ahcd/ahcd-questionnaires.htm. Accessed 21 August 2012.
13. Suh DC, Lau H, Pokras SM, Choi IS, Valiyeva E. Sex differences in ambulatory visits for chronic obstructive pulmonary disease, based on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey from 1995 to 2004. Respir Care 2008; 53(11):1461-1469.
14. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2001. Accessed 24 August 2012.
15. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2003). 2003. Available from: http://www.goldcopd.org/uploads/ users/files/GOLDWkshp2003Clean.pdf. Accessed 24 August 2012.
16. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2004). 2004. Available from: http://www.goldcopd.org/uploads/ users/files/GOLDWkshp2004Clean.pdf. Accessed 24 August 2012.
17. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2005). 2005. Available from: http://www.goldcopd.org/uploads/ users/files/GOLDWkshp05Clean.pdf. Accessed 24 August 2012.
18. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2006). 2006. Available from: http://www.goldcopd.org/uploads/ users/files/GOLDReport2006-0122.pdf. Accessed 24 August 2012.
19. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2007). 2007. Available from: http://www.goldcopd.org/uploads/ users/files/GOLDReport07-0108.pdf. Accessed 24 August 2012.
20. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009). 2009. Available from: http://www.goldcopd.com/ Guidelineitem.asp?l1=2&l2=1&intId=2003. Accessed 7 January 2011.